Marshall Natalie C, Thejoe Maichael, Klein Theo, Serapio-Palacios Antonio, Santos Andrew S, von Krosigk Niklas, Kizhakkedathu Jayachandran N, Stoynov Nikolay, Foster Leonard J, Overall Christopher M, Finlay B Brett
Department of Microbiology & Immunology, University of British Columbia, Vancouver, Canada.
Michael Smith Laboratories, University of British Columbia, Vancouver, Canada.
mSystems. 2020 Jun 2;5(3):e00283-20. doi: 10.1128/mSystems.00283-20.
Enteropathogenic (EPEC) causes severe diarrheal disease and is present globally. EPEC virulence requires a bacterial type III secretion system to inject >20 effector proteins into human intestinal cells. Three effectors travel to mitochondria and modulate apoptosis; however, the mechanisms by which effectors control apoptosis from within mitochondria are unknown. To identify and quantify global changes in mitochondrial proteolysis during infection, we applied the mitochondrial terminal proteomics technique itochondrial table isotope labeling by amino acids in cell culture-erminal mine sotopic abeling of ubstrates (MS-TAILS). MS-TAILS identified 1,695 amino N-terminal peptides from 1,060 unique proteins and 390 N-terminal peptides from 215 mitochondrial proteins at a false discovery rate of 0.01. Infection modified 230 cellular and 40 mitochondrial proteins, generating 27 cleaved mitochondrial neo-N termini, demonstrating altered proteolytic processing within mitochondria. To distinguish proteolytic events specific to EPEC from those of canonical apoptosis, we compared mitochondrial changes during infection with those reported from chemically induced apoptosis. During infection, fewer than half of all mitochondrial cleavages were previously described for canonical apoptosis, and we identified nine mitochondrial proteolytic sites not previously reported, including several in proteins with an annotated role in apoptosis, although none occurred at canonical Asp-Glu-Val-Asp (DEVD) sites associated with caspase cleavage. The identification and quantification of novel neo-N termini evidences the involvement of noncaspase human or EPEC protease(s) resulting from mitochondrial-targeting effectors that modulate cell death upon infection. All proteomics data are available via ProteomeXchange with identifier PXD016994 To our knowledge, this is the first study of the mitochondrial proteome or N-terminome during bacterial infection. Identified cleavage sites that had not been previously reported in the mitochondrial N-terminome and that were not generated in canonical apoptosis revealed a pathogen-specific strategy to control human cell apoptosis. These data inform new mechanisms of virulence factors targeting mitochondria and apoptosis during infection and highlight how enteropathogenic (EPEC) manipulates human cell death pathways during infection, including candidate substrates of an EPEC protease within mitochondria. This understanding informs the development of new antivirulence strategies against the many human pathogens that target mitochondria during infection. Therefore, itochondrial table isotope labeling by amino acids in cell culture-erminal mine sotopic abeling of ubstrates (MS-TAILS) is useful for studying other pathogens targeting human cell compartments.
肠致病性大肠杆菌(EPEC)可引发严重腹泻疾病,在全球范围内均有存在。EPEC的毒力需要细菌III型分泌系统将20多种效应蛋白注入人类肠道细胞。三种效应蛋白进入线粒体并调节细胞凋亡;然而,效应蛋白在线粒体内控制细胞凋亡的机制尚不清楚。为了识别和量化感染期间线粒体蛋白水解的全局变化,我们应用了线粒体末端蛋白质组学技术——细胞培养中氨基酸的线粒体末端同位素标记——底物的末端微量同位素标记(MS-TAILS)。MS-TAILS以0.01的错误发现率从1060种独特蛋白质中鉴定出1695个氨基N端肽段,从215种线粒体蛋白质中鉴定出390个N端肽段。感染改变了230种细胞蛋白和40种线粒体蛋白,产生了27个切割后的线粒体新N端,表明线粒体内蛋白水解过程发生了改变。为了区分EPEC特有的蛋白水解事件与经典细胞凋亡的事件,我们将感染期间的线粒体变化与化学诱导细胞凋亡报告的变化进行了比较。在感染期间,所有线粒体切割中只有不到一半是先前描述的经典细胞凋亡事件,我们还鉴定出9个先前未报道的线粒体蛋白水解位点,包括一些在细胞凋亡中具有注释作用的蛋白质中的位点,但没有一个发生在与半胱天冬酶切割相关的经典天冬氨酸-谷氨酸-缬氨酸-天冬氨酸(DEVD)位点。对新型新N端的鉴定和量化证明了非半胱天冬酶人类或EPEC蛋白酶的参与,这些蛋白酶是由靶向线粒体的效应蛋白产生的,可在感染时调节细胞死亡。所有蛋白质组学数据可通过ProteomeXchange获得,标识符为PXD016994。据我们所知,这是第一项关于细菌感染期间线粒体蛋白质组或N端蛋白质组的研究。在线粒体N端蛋白质组中先前未报道且在经典细胞凋亡中未产生的已鉴定切割位点揭示了一种病原体特异性策略来控制人类细胞凋亡。这些数据为感染期间毒力因子靶向线粒体和细胞凋亡的新机制提供了信息,并突出了肠致病性大肠杆菌(EPEC)在感染期间如何操纵人类细胞死亡途径,包括线粒体内EPEC蛋白酶的候选底物。这一认识为开发针对许多在感染期间靶向线粒体的人类病原体的新抗毒力策略提供了依据。因此,细胞培养中氨基酸的线粒体末端同位素标记——底物的末端微量同位素标记(MS-TAILS)对于研究其他靶向人类细胞区室的病原体很有用。